Diabetes mellitus contributes to 15–25% of all chronic foot ulcers. Peripheral vascular
disease is a cause of ischemic ulcers and exacerbates diabetic foot disease. Cell-based …

Cell-based therapy is an attractive approach for the treatment of chronic nonhealing
wounds. This study investigated whether adipose-derived stem cells (ASCs) can accelerate …

Background Adipose-derived mesenchymal stem cells (ASCs) therapy is emerging as a
novel therapeutic option for the treatment of a variety of diseases including diabetes and …

Adipose tissue–derived stem cells (ASC s) are gaining increasing consideration in tissue
repair therapeutic application. Recent evidence indicates that ASC s enhance skin repair in …

Despite advances in wound closure techniques and devices, there is still a critical need for
new methods of enhancing the healing process to achieve optimal outcomes. Recently …

Background Wound healing is impaired in patients with diabetes due to the multifactorial
etiology of the disease, which limits the therapeutic efficacy of various approaches. This …

Background Application of autologous adipose-derived stem cells (ASC) for diabetic chronic
wounds has become an emerging treatment option. However, ASCs from diabetic …

This review provides an outline of the use of adipose-derived mesenchymal stem cells
(AMSCs) in the treatment of diabetic foot ulcers (DFUs). A systematic search of PubMed and …

With the increasing global prevalence of diabetes mellitus, a significant rise in the number of
patients suffering from non-healing wounds is expected. However, available treatments …

A diabetic wound is one of the major complications of Diabetes mellitus. Considering the
impact of these wounds on the health and quality of life of diabetic patients, the need for a …